112 related articles for article (PubMed ID: 11729853)
1. In vitro and in vivo matrix metalloproteinase production by pancreatic cancer cells and by distant organs.
Haq M; Shaeii AE; Zervos EE; Rosemurgy AS
Int J Surg Investig; 2000; 1(6):459-65. PubMed ID: 11729853
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
Zervos EE; Shafii AE; Rosemurgy AS
J Surg Res; 1999 Jan; 81(1):65-8. PubMed ID: 9889060
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro.
Zervos EE; Shafii AE; Haq M; Rosemurgy AS
J Surg Res; 1999 Jun; 84(2):162-7. PubMed ID: 10357914
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo.
Zervos EE; Norman JG; Gower WR; Franz MG; Rosemurgy AS
J Surg Res; 1997 May; 69(2):367-71. PubMed ID: 9224409
[TBL] [Abstract][Full Text] [Related]
5. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
[TBL] [Abstract][Full Text] [Related]
6. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis.
Bloomston M; Shafii A; Zervos EE; Rosemurgy AS
J Surg Res; 2002 Jan; 102(1):39-44. PubMed ID: 11792150
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay.
Schneiderhan W; Diaz F; Fundel M; Zhou S; Siech M; Hasel C; Möller P; Gschwend JE; Seufferlein T; Gress T; Adler G; Bachem MG
J Cell Sci; 2007 Feb; 120(Pt 3):512-9. PubMed ID: 17227797
[TBL] [Abstract][Full Text] [Related]
8. [Effect of hypoxia on production and secretion of matrix metalloproteinases in tumor cells].
Gao Y; Wang JJ; Wang GF; Xu Q; Guo J
Ai Zheng; 2005 Feb; 24(2):180-3. PubMed ID: 15694029
[TBL] [Abstract][Full Text] [Related]
9. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
Matsuyama Y; Takao S; Aikou T
J Surg Oncol; 2002 Jun; 80(2):105-10. PubMed ID: 12173379
[TBL] [Abstract][Full Text] [Related]
10. Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines.
Bredin CG; Liu Z; Klominek J
Anticancer Res; 2003; 23(6C):4877-84. PubMed ID: 14981939
[TBL] [Abstract][Full Text] [Related]
11. TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo.
Bloomston M; Shafii A; Zervos E; Rosemurgy AS
Am J Surg; 2005 Jun; 189(6):675-9. PubMed ID: 15910719
[TBL] [Abstract][Full Text] [Related]
12. Glial cell-derived neurotrophic factor upregulates the expression and activation of matrix metalloproteinase-9 in human pancreatic cancer.
Okada Y; Eibl G; Duffy JP; Reber HA; Hines OJ
Surgery; 2003 Aug; 134(2):293-9. PubMed ID: 12947332
[TBL] [Abstract][Full Text] [Related]
13. Distinct patterns of matrix metalloproteinase-2 and -9 expression in normal human cell lines.
Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2009 Mar; 21(3):821-6. PubMed ID: 19212645
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells.
Kawakami S; Kageyama Y; Fujii Y; Kihara K; Oshima H
Anticancer Res; 2001; 21(1A):213-9. PubMed ID: 11299737
[TBL] [Abstract][Full Text] [Related]
15. Role of fibrillar Tenascin-C in metastatic pancreatic cancer.
Chen J; Chen Z; Chen M; Li D; Li Z; Xiong Y; Dong J; Li X
Int J Oncol; 2009 Apr; 34(4):1029-36. PubMed ID: 19287959
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
[TBL] [Abstract][Full Text] [Related]
17. MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer.
Bloomston M; Shafii A; Zervos EE; Rojiani A; Rosemurgy AS
J Surg Res; 2002 Jan; 102(1):35-8. PubMed ID: 11792149
[TBL] [Abstract][Full Text] [Related]
18. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effects of high mobility group box 1 antisense nucleotide on invasion of human pancreatic cancer cell line PCNA-1].
Huang QX; Wang GB; Sun NF; Wang CY
Ai Zheng; 2004 Sep; 23(9):1036-40. PubMed ID: 15363197
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo.
Kapischke M; Fischer T; Tiessen K; Tschesche H; Bruch HP; Kalthoff H; Kruse ML
Int J Oncol; 2008 Jan; 32(1):273-82. PubMed ID: 18097568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
